-
Workplace influenza vaccination in private hospital setting: a cost-benefit analysis
-
Mohd. Ab. Hadi Tohiar, Safurah Jaafar, Azimatun Noor Aizuddin, Tan Kok Leong, Azrin Syahida Abdul Rahim
-
Ann Occup Environ Med 2022;34:e3. Published online February 17, 2022
-
DOI: https://doi.org/10.35371/aoem.2022.34.e3
-
-
Abstract
PDFPubReaderePub
- Background
Influenza illness causes several disruptions to the workforce. The absenteeism that often ensues has economic implications for employers. This study aimed to estimate the cost-benefit of influenza vaccination in a healthcare setting from the employer’s perspective. MethodsA cross-sectional questionnaire survey was conducted in a private hospital in 2018–2019 comparing voluntary vaccinated with non-vaccinated employees with influenza vaccine. The analyses were made based on self-reporting on absenteeism and presenteeism from Influenza-like illnesses (ILIs). The costs incurred, both direct and indirect costs, were included in the study. A cost-benefit analysis was performed by measuring the cost of the vaccination program. The costs of absenteeism and reduced productivity were calculated using 3 hypothesised levels of effectiveness in the following percentage of productivity of 30%, 50%, and 70%. The costs were also calculated based on four scenarios: with and without operating income and with and without replacement. The benefits of the influenza vaccination from the employer’s perspective were analysed. The benefit to cost ratio was determined. ResultsA total of four hundred and twenty-one respondents participated. The influenza vaccination rate was 63.0%. The rate of ILI of 38.1% was significantly lower among vaccinated. The ILI-related absenteeism reported was also significantly lower amongst vaccinated employees at 30% compared to 70% non-vaccinated. Employers could save up to USD 18.95 per vaccinated employee when only labour cost was included or 54.0% of cost savings. The cost-saving rose to USD 155.56 when the operating income per employee was also included. The benefit to cost ratio confirmed that the net cost-benefit gained from the vaccination was more than the net cost of vaccination. ConclusionsInfluenza vaccination for working adults was cost-saving and cost-beneficial when translated into financial investments for the employer. A workplace vaccination demonstrates a significant cost-benefit strategy to be applied in any institutional setting.
-
Citations
Citations to this article as recorded by
- Association between long working hours and engagement in preventive healthcare services in Korean workers: Findings from the Korean National Health and Nutrition Examination Survey
Seong-Uk Baek, Yu-Min Lee, Jin-Ha Yoon Preventive Medicine.2024; 180: 107849. CrossRef - Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022
Radhika Gharpure, Anna N. Chard, Maria Cabrera Escobar, Weigong Zhou, Molly M. Valleau, Tat S. Yau, Joseph S. Bresee, Eduardo Azziz-Baumgartner, Sarah W. Pallas, Kathryn E. Lafond, Sydney Rosen PLOS Medicine.2024; 21(1): e1004333. CrossRef
-
50
View
-
0
Download
-
2
Web of Science
-
2
Crossref
|